{"ticker": {"uuid": "54a9e28b-9655-4283-bec8-e686a4cab441", "symbol": "1228", "name": "CANbridge Pharmaceuticals Inc.", "exchange": "HKG", "country": "HK", "sector": "Healthcare", "industry": "Biotechnology"}, "articles": [{"title": "CANbridge Calls Virtual EGM to Approve WuXi Biologics Service Framework", "summary": "", "url": "https://news.google.com/rss/articles/CBMiwAFBVV95cUxNTnNWTldlSFVLWHRGLUtkNTVNNGdQZ0NnOTdkTWRMWWxwT1lCS3c3NmU0OWhnYWVoUGxHN3hQRG1lSWtYalNBeWZ0TG13SzhHaXRBckd2SGlKaWxHU3Y3ZjljRXZzZG5veE03TFRZZkpQQlo1QUsyVHNNUGtkZ0s1T3BldGRkV1AyR2VEWWNRZzBVVEFKWXBSUXNDUFhzTHZ4R3R0VkVxY3AtX3NXOFI4UUNvNC10NGlqOTZ1V3hiTV8?oc=5", "source_name": "TipRanks", "published_at": "2026-07-15T14:41:08+00:00", "published_display": "15 Jul 2026 14:41", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "CANbridge delays shareholder circular on WuXi Biologics framework deal", "summary": "", "url": "https://news.google.com/rss/articles/CBMivwFBVV95cUxNUmJKclBqZ0FnUWcyM2VlQngyTEVUZ1kweFI5NmhQRXVvUkNWTl9uNzRyMmZtUExndldWdDh3VXNQb0JqMExUNmdiN2xCRmpRYV9ySGJPaUgwNGRyUnJXcWk3bGZ0ZWV0Q0dkNlM3M2VGUEJqWGI3OUY1RXJtNUxYeUpoVk1aT2ZOZ0pNcjNNcUVnMmRwc2tVMkhCckd6cWprS2docVRzNDJmakRqMlY4elNueFlGVW94bDA2ZnBRZw?oc=5", "source_name": "TipRanks", "published_at": "2026-07-09T08:43:41+00:00", "published_display": "09 Jul 2026 08:43", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "BRIEF: CANbridge raises $26 million in share sale to WuXi Bio at 14.7% discount", "summary": "", "url": "https://news.google.com/rss/articles/CBMinwFBVV95cUxPSGVIZnE5Mng3V0JPWnYzMHc3OVMyZWRqeVpvUWNWamllNWlRaTRvMVBWcE53Q0VZY1FUMHVLNDZuYUdaN1VxbVNoR3ZweTBzX0JEZ1NUSU16UnE1b25PSkJ1MDJwV2FYTVBiNzEyMXFCRmRzQnFwd0lOeDZZbkI5MFlGQmhHd01ka1pxTjE4SVhnRVRjQ2RHVmdteUF5Vnc?oc=5", "source_name": "thebambooworks.com", "published_at": "2026-02-16T08:00:00+00:00", "published_display": "16 Feb 2026 08:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "CANbridge Pharmaceuticals Completes US$98 Million Series D Financing Led by General Atlantic and WuXi AppTec", "summary": "", "url": "https://news.google.com/rss/articles/CBMi6gFBVV95cUxNZE5rU29DZkVneDhWcXpCUUFTSXk5SWIwTXBoVEdPdk84SldLWGJKbHZhc0g3WnhCYy1QWU9TWlJLREFSUlhOenNWTjROZkJ2TlBMeGFlbk5IcHFxOHh0QXpkTk56NnN3ZDJ2djZZZTlOalA5R2c1QlQzWVRQWm5PQWtrb21rZm5iT3lwZXdiakdQZnB2ZnhON3ZycktZWExyaVlJWTdaZDVTdlNldnNYSmx4OUw4UFhCRHNnTG5id2tBalp2VDc1ekI0UFgyR0gwbWNINUVJNDYyREFfUUhYVGpwTUs3UjBwYVE?oc=5", "source_name": "General Atlantic", "published_at": "2020-02-18T08:00:00+00:00", "published_display": "18 Feb 2020 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "by_tier": {"direct": [{"title": "CANbridge Calls Virtual EGM to Approve WuXi Biologics Service Framework", "summary": "", "url": "https://news.google.com/rss/articles/CBMiwAFBVV95cUxNTnNWTldlSFVLWHRGLUtkNTVNNGdQZ0NnOTdkTWRMWWxwT1lCS3c3NmU0OWhnYWVoUGxHN3hQRG1lSWtYalNBeWZ0TG13SzhHaXRBckd2SGlKaWxHU3Y3ZjljRXZzZG5veE03TFRZZkpQQlo1QUsyVHNNUGtkZ0s1T3BldGRkV1AyR2VEWWNRZzBVVEFKWXBSUXNDUFhzTHZ4R3R0VkVxY3AtX3NXOFI4UUNvNC10NGlqOTZ1V3hiTV8?oc=5", "source_name": "TipRanks", "published_at": "2026-07-15T14:41:08+00:00", "published_display": "15 Jul 2026 14:41", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "CANbridge delays shareholder circular on WuXi Biologics framework deal", "summary": "", "url": "https://news.google.com/rss/articles/CBMivwFBVV95cUxNUmJKclBqZ0FnUWcyM2VlQngyTEVUZ1kweFI5NmhQRXVvUkNWTl9uNzRyMmZtUExndldWdDh3VXNQb0JqMExUNmdiN2xCRmpRYV9ySGJPaUgwNGRyUnJXcWk3bGZ0ZWV0Q0dkNlM3M2VGUEJqWGI3OUY1RXJtNUxYeUpoVk1aT2ZOZ0pNcjNNcUVnMmRwc2tVMkhCckd6cWprS2docVRzNDJmakRqMlY4elNueFlGVW94bDA2ZnBRZw?oc=5", "source_name": "TipRanks", "published_at": "2026-07-09T08:43:41+00:00", "published_display": "09 Jul 2026 08:43", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "BRIEF: CANbridge raises $26 million in share sale to WuXi Bio at 14.7% discount", "summary": "", "url": "https://news.google.com/rss/articles/CBMinwFBVV95cUxPSGVIZnE5Mng3V0JPWnYzMHc3OVMyZWRqeVpvUWNWamllNWlRaTRvMVBWcE53Q0VZY1FUMHVLNDZuYUdaN1VxbVNoR3ZweTBzX0JEZ1NUSU16UnE1b25PSkJ1MDJwV2FYTVBiNzEyMXFCRmRzQnFwd0lOeDZZbkI5MFlGQmhHd01ka1pxTjE4SVhnRVRjQ2RHVmdteUF5Vnc?oc=5", "source_name": "thebambooworks.com", "published_at": "2026-02-16T08:00:00+00:00", "published_display": "16 Feb 2026 08:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "CANbridge Pharmaceuticals Completes US$98 Million Series D Financing Led by General Atlantic and WuXi AppTec", "summary": "", "url": "https://news.google.com/rss/articles/CBMi6gFBVV95cUxNZE5rU29DZkVneDhWcXpCUUFTSXk5SWIwTXBoVEdPdk84SldLWGJKbHZhc0g3WnhCYy1QWU9TWlJLREFSUlhOenNWTjROZkJ2TlBMeGFlbk5IcHFxOHh0QXpkTk56NnN3ZDJ2djZZZTlOalA5R2c1QlQzWVRQWm5PQWtrb21rZm5iT3lwZXdiakdQZnB2ZnhON3ZycktZWExyaVlJWTdaZDVTdlNldnNYSmx4OUw4UFhCRHNnTG5id2tBalp2VDc1ekI0UFgyR0gwbWNINUVJNDYyREFfUUhYVGpwTUs3UjBwYVE?oc=5", "source_name": "General Atlantic", "published_at": "2020-02-18T08:00:00+00:00", "published_display": "18 Feb 2020 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "industry": [], "sector": []}, "total_fetched": 80, "total_relevant": 4, "sentiment_summary": {"positive": 1, "negative": 0, "neutral": 3, "score": 53, "total": 4, "label": "Balanced news tone", "tone": "neutral"}, "classifier": {"primary_event": "general", "primary_label": "Market update", "confidence": 71, "events": [{"event": "general", "label": "Market update", "weight": 1.65, "count": 3}, {"event": "deals", "label": "Deals and strategy", "weight": 0.55, "count": 1}], "positive_events": 1, "negative_events": 0}, "market_context": {"has_market_context": true, "latest_close": 2.03, "latest_week": "2026-07-10", "one_week_move": 2.5, "four_week_move": 2.0, "twelve_week_move": -23.4, "trend_signal": "0", "trend_label": "Trend inactive", "trend_tone": "negative", "market_dynamics": -1.090487, "market_dynamics_buy_signal": false, "relative_strength": -2.278135, "fair_value_gap": 85.0, "fair_value_label": "Materially above fair value", "fair_value_tone": "negative", "expectation_direction": "negative", "expectation_probability": 33.9145, "reaction_label": "Price confirming higher", "reaction_tone": "positive", "market_sentence": "+2.5% over one week, +2.0% over four weeks, trend inactive, and materially above fair value."}, "interpretation": {"label": "Balanced read", "tone": "neutral", "classification": "balanced", "summary": "News tone and price action are not far from neutral.", "confidence": 58, "badges": [], "opportunities": [], "risks": [], "event_label": "Market update", "sentiment_word": "balanced"}, "charts": {"sources": [{"label": "TipRanks", "count": 2}, {"label": "thebambooworks.com", "count": 1}, {"label": "General Atlantic", "count": 1}], "tiers": [{"label": "Direct company coverage", "count": 4}, {"label": "Industry context", "count": 0}, {"label": "Sector context", "count": 0}], "events": [{"label": "Market update", "count": 3}, {"label": "Deals and strategy", "count": 1}]}, "insights": [{"label": "Weighted tone", "value": "53/100", "tone": "neutral", "text": "Balanced news tone"}, {"label": "Market reaction", "value": "Balanced read", "tone": "neutral", "text": "News tone and price action are not far from neutral."}, {"label": "Primary event", "value": "Market update", "tone": "neutral", "text": "71/100 classification confidence."}, {"label": "Company focus", "value": "4", "tone": "positive", "text": "directly relevant articles"}, {"label": "Source quality", "value": "0", "tone": "neutral", "text": "high-authority source matches"}, {"label": "Trend context", "value": "Trend inactive", "tone": "negative", "text": "+2.5% over one week, +2.0% over four weeks, trend inactive, and materially above fair value."}, {"label": "Latest direct headline", "value": "Neutral", "tone": "neutral", "text": "CANbridge Calls Virtual EGM to Approve WuXi Biologics Service Framework"}], "updated_at": "2026-07-18T01:16:51.618321+00:00", "disclaimer": "Educational market research only. Not financial, investment, trading, tax, or legal advice."}